
































GH.! IGFb1! insensitivity! results! in! preb! and! postbnatal! growth! failure!with! normal/high! IGFb1! levels.!31!
The!prevalence!of!genetic!defects!is!unknown.!!32!
Objective:! To! identify! the! underlying! genetic! diagnoses! in! a! paediatric! cohort! with! GH! or! IGFb1!33!
insensitivity! using! candidate! gene! (CGS)! and! whole! exome! sequencing! (WES)! and! assess! factors!34!
associated!with!the!discovery!of!a!genetic!defect.!35!
Methods:!We!undertook!a!prospective!study!of!132!patients!with!short!stature!and!suspected!GH!or!36!
IGFb1! insensitivity! referred! to! our! centre! for! genetic! analysis.! 107! (96!GHI,! 88! probands;! 11! IGFb1!37!
insensitivity,! 9! probands)! underwent! CGS.!WES! was! performed! in! those! with! no! defined! genetic!38!
aetiology!following!CGS.!!39!
Results:&A! genetic! diagnosis! was! discovered! 38/107! (36%)! patients! (32%! probands)! by! CGS.!WES!40!
revealed! 11! patients! with! genetic! variants! in! genes! known! to! cause! short! stature.! A! further! 2!41!




Conclusions:& Comprehensive! genetic! testing! confirms! the! genetic! heterogeneity! of! GH/IGFb1!46!
insensitivity!and!successfully!identified!the!genetic!aetiology!in!a!significant!proportion!of!cases.!WES!47!



















IGF18.! IGFb1! insensitivity! secondary! to! IGF1R, gene!mutations! exists! as! part! of! the! continuum! and!66!
leads!to!a!similar!phenotype9.!In!cases!of!IGFb1!resistance,!the!IGFb1!levels!are!high10.!Depending!on!67!
the!genetic!defect,!associated!clinical!and!dysmorphic!features!may!be!present!including:!midbfacial!68!
hypoplasia! and! frontal! bossing! (GHR,, STAT5B)4,! 11,! immune! deficiency! (STAT5B)4,! pubertal! delay!69!
(IGFALS,, STAT5B,, GHR)4,! 11,! 12,! decreased! bone! mineral! density! (PAPPA2)7,! developmental! delay,!70!
microcephaly! and! in7utero! growth! retardation! (IGF1,, IGF1R)1.! 3M,! SilverbRussell! (SRS)! and!Noonan!71!
(NS)! syndromes!have!phenotypes! that!can!overlap!with!GHI10,! 13,! 14.!3M!syndrome! (OMIM!273750)!72!
results! in!preb!and!postbnatal!growth! restriction,!prominent!heels,! facial!dysmorphism!and!distinct!73!
radiological! features15.!The!genetics!are! incompletely!understood,!but!mutations! in!cullin!7! (CUL7)!74!
(70%),!obscurinblike!1! (OBSL1)! (25%)!and!coiled!coil!domainbcontaining!8! (CCDC8)! (5%)!genes!have!75!
been!identified16,!17.!SRS!is!characterized!by!intrauterine!and/or!postnatal!growth!retardation!and!is!76!
caused!by!maternal!uniparental!disomy!of!chromosome!seven!(matUPD7)!and!hypomethylation!of!77!














(WES).!CGS! is!clinically!driven!and! is! reliable!when!the!affected!gene!can!be!predicted!with!a!high!91!
degree! of! certainty.! Its! success! depends! on! the! accurate! clinical! phenotyping! of! patients! and! is!92!
limited! in! growth! disorders! with! overlapping,! highly! variable! or! subtle! features22.! It! is! also! timeb93!
consuming!and!costly!if!a!number!of!genes!are!analysed.!In!contrast,!WES!allows!the!simultaneous!94!
screening! of! the! entire! coding! DNA! of! an! individual! and! is! therefore! extremely! cost! effective! if!95!
multiple!genes!are!to!be!investigated.!!96!
!97!
As! a! genetic! reference! centre,! we! undertook! CGS! in! a! cohort! of! patients! with! short! stature! and!98!
suspected! GH! or! IGFb1! insensitivity.! This! is! an! extension! of! our! previous! work! and! some! of! the!99!
patients! have! been! previously! reported10.! WES! was! completed! in! patients! with! no! diagnosis!100!












home! institutions! and! the! referring! physicians! completed! a! proforma! detailing! the! clinical! and!112!
biochemical!data!at!the!time!of!sending!the!DNA!sample.!The!referring!clinicians!excluded!causes!of!113!
secondary! GHI,! including! undernutrition.! Birth! weight,! height,! and! BMI! were! expressed! as! SDS!114!
according! to! the!appropriate!national! standards.!Biochemical! investigations! included:!basal!and/or!115!
peak!GH!and!basal! IGFb1! levels.! IGFb1!was!expressed!as!SDS!based!on!the!age!and!sex!appropriate!116!
range!provided!by!the!institution.!Where!serum!IGFb1!was!undetectable!(less!than!the!lower!limit!of!117!





insensitivity!and!were!excluded! (Figure&1A).!Diagnoses! in! the!excluded!group! included!GHD! (n=4),!123!
short! stature! associated! with! chromosome! 10! duplication! (n=1)! and! achondroplasia! (FGFR3!124!
mutation)! (n=1).! One! hundred! and! seven! cases! (97! families,! 97! probands)! were! investigated,!125!







Genomic! DNA! was! isolated! from! peripheral! blood! leukocytes! (Qiagen! DNeasy! Kit)! and! genetic!133!
analysis!was!undertaken!on!all!patients!as!previously!described10.!The!candidate!genes! sequenced!134!
! 6!
depended!on! the! clinical! and!biochemical! features.!Most!patients!were! screened! for!mutations! in!135!
the!growth!hormone!receptor!gene!(GHR);!other!genes!were!selected!depending!on!the!phenotype!136!
(Figure& 1A).! Sanger! sequencing! was! performed! by! the! Barts! and! the! London! Genome! Centre!137!
(http://www.smd.qmul.ac.uk/gc/)! or! GATC! Biotech! (https://www.gatcbbiotech.com).! 2! patients!138!








Twentybthree! patients! and! 3! relatives! were! processed! using! the! Agilent! SureSelect! all! exon! V4!147!
capture!and!pairedbend! (2!x!100)! sequencing!on!an! Illumina!HiSeq!2000!at!Otogenetics! (Norcross,!148!
GA).!31!patients!and!8!relatives!were!sequenced!using!SureSelect!Human!All!Exon!v5!(51Mb)!capture!149!
and!pairedbend!(2!x!100)!sequencing!on!an!Illumina!2500!Standard!run!(minimum!coverage!50x)!at!150!






View,! CA,! USA)! by! aligning! to! the! H.! sapiens! GRCh37–b37! (1000! genomes! Phase! 1)! reference!157!
genome!with!BWAbMEM!FastQ!Readmapper!VCF! files,! generated!by!Vendor!Human!Exome!GATKb158!






frequency! of! ≥0.1%! in! the! 1000! genomes,! ExAC! and! the! NHLBI! exomes.!Missense! variations! that!164!
were! classified! as! loss! of! function! by! Ingenuity! were! included! i.e.! the! amino! acid! change! was!165!








assess! the! segregation! of! the! variant!within! family! structures.! If! no! putative! causal! variants!were!174!
found!we!progressed!to!analysis!2.!175!
!176!




parents.!Variants!were!only! included! if! they!were!present! in!patients!and!absent! in!controls.!Since!181!
the!cohort! is!genetically!and!phenotypically!heterogeneous,!we!hypothesized!that!the!same!causal!182!
variant! was! unlikely! to! be! seen! in! multiple! patients! (barring! related! individuals).! Therefore,! any!183!
variants! that! were! present! in! ≥3! patients! were! discarded.! If! no! putative! causal! variants! were!184!
identified!by!these!criteria!we!progressed!to!analysis!3.!185!
!186!




this! strategy! may! miss! private! mutations,! it! provides! corroborative! evidence! that! the! gene! is!190!
implicated! in! the! phenotype.! As! above,! identical! variants! that! were! present! in! ≥3! patients! were!191!











Novel!variants!were! investigated! in,silico!by!SIFT! (score!ranges! from!0! (predicted!deleterious)! to!1!203!
(predicted! benign)),! PolyPhenb2! (score! ranges! from! 0! (predicted! benign)! to! 1! (predicted!204!
deleterious)),! Variant! effect! predictor! (VEP),! Mutation! Taster! and! Human! Splicing! Finder! (HSF!205!
version! 3.0)! to! predict! the! functional! outcome.! VEP! defines! the! likely! deleterious! effect! of! the!206!
variant!as!low,!moderate,!or!high.!Mutation!Taster!predicts!whether!the!variant!is!predicted!disease!207!















CGS! identified! likely! causative! variants! in! 35! GHI! patients! (28! probands)! and! 3! IGFb1! insensitivity!222!
patients,!all!probands!(total!38/107;!36%!or!31/97,!32%!probands)!(Table&1).!These!included!variants!223!
in!GHR,(n=27,patients),!IGFALS,(n=3,patients),!OBSL1,(n=6,patients),!CUL7,(n=1,patients)!and!IGF1R,224!
(n=1! patient), (Figures& 1A& and& 2).! 30! of! 38! (79%)! children! diagnosed! by! CGS! had! consanguineous!225!
parents.!STAT5B!sequencing!was!normal!in!the!3!patients!tested.!226!
!227!
GHR:! Fifteen! GHR! variants! (5! novel! and! 10! previously! described)! were! identified! in! 27! patients!228!
(patients!1b27,!Table&1)!with!mean!serum!IGFb1!b3.5!SDS!(range!b8.5!to!b2.3),!mean!basal!and!peak!229!
GH! concentrations!40.7!μg/l! (range!1.8! to!398,!n=21)! and!123.2!μg/l! (range!15.7–1195,!n=20).!All!230!
had! homozygous! variants! in!GHR!with! the! exception! of! 2! patients! (21!&! 26)!who! had! compound!231!
heterozygous!variants,!inheriting!one!defective!allele!from!each!parent.!All!children!except!patient!1!232!




characteristic! features! of! GHI! (height! SDS! b4.0,! IGF1! SDS! b2.6,! peak! GH! levels! 119! μg/l)! but! no!237!
dysmorphic! features.! Four! of! the! novel! GHR, variants! were! homozygous;! c.198C>A! (p.Cys66*),!238!
c.700C>T!(p.Gln234*),!c.599A>G!(p.Asn200Ser)!c.344A>C!(p.Asn115Thr)!all!predicted!deleterious!by!239!
at!least!one!functional!outcome!prediction!method.!Patient!21!had!2!previously!described!variants!in!240!
compound!heterozygosity! (c.266+83G>T! (p.?)! and! (c.723C>T,!p.Gly241_Glu261del).! The! final!novel!241!
! 10!
variant,! c.922G>A! (p.Gly308Arg)! predicted! deleterious! by! SIFT,! was! found! in! compound!242!
heterozygosity! with! a! known! GHR! variant! in! patient! 26.! Other! known! GHR,mutations! identified!243!
were:! c.740T>C! (p.Leu247Pro),! c.594A>G! (p.Glu198*),! c.785b6! T>A! (p.Asp264Glyfx*),! c.247C>T!244!




1.9)! and! mean! peak! GH! concentration! 20.5! μg/L! (16.0! to! 28.9! μg/L).! One! variant! c.1291delT,!249!
pTrp431Glyfs*11! has! been! previously! described! 10.! Interestingly,! the! previously! described!250!




(p.Arg489*)! (patients! 31! and! 32)! and! c.1359insA,! (p.Glu454Argfs*)! (patients! 33b36)! and, 1!255!
homozygous, CUL7, c.2710C>T! (p.Arg904*), mutation! (patient! 37), 23,! 24.! ! All! patients! had!256!
consanguineous!parents.!All!patients!had!severe!short!stature! (mean!height!SDS! b5.8)!with!normal!257!
GH!(mean!peak!GH!21.8).!Most!had!severe!IGFb1!deficiency!but!2!(patients!35!&!37)!had!IGFb1!levels!258!
of! b0.2! and! b0.25,! respectively.! Additional! but! variable! clinical! features! of! the! 3M! syndrome!were!259!
present!in!all!7!patients!(Table&1).&260!
!261!
IGF1R:! A! heterozygous! missense! variant! was! identified! in! one! patient! with! an! IGFb1! insensitivity!262!














Analysis, 1, (Table& 2& and& Figure& 2):! 11/54! patients! (20%)! (10! probands,! 19%)! were! found! to! have!276!
variants! in! genes! known! to! cause! GHI! (homozygous, GHR! (n=5),! compound! heterozygous, IGFALS!277!






Kuwaiti! origin,! therefore! a! founder! effect! is! likely.! Patient! 51! had! a! previously! described! GHR!284!
c.703C>T,! p.Arg235*! (R217X)!mutation,! ! and! had! a! clinical! picture! of! classical! Laron! syndrome!with!285!
height!SDS!b5.9,!IGFb1!of!b5.3,!and!peak!GH!>35.!!286!
!287!
IGFALS:! Patient! 46! (Table& 2)& with! novel! compound! heterozygous! IGFALS! variants! c.1576G>A!288!
(p.Asp526Asn)! and! c.632G>A,! (p.Trp211*),! both!predicted!deleterious! (SIFT! score!0),! had!a! typical!289!
phenotype!(height!SDS!b5.0,!IGF1!SDS!b2.5!and!peak!GH!13!μg/L).!!290!
!291!
Noonan, syndrome, (NS), genes:! Patients! 41! and! 42! had! previously! described! heterozygous!PTPN11!292!
c.417G>C! (p.Glu139Asp)! and! c.853T>C! (p.Phe285Leu)!mutations! 25.! Both!had! short! stature! (height!293!
! 12!
SDS!b2.1!and!b3.1),!IGFb1!deficiency!(b2.3!andb2.4),!dysmorphic!features!and!were!SGA!(birth!weight!294!
SDS! b2.1! and! b3.0).! The! phenotype! of! the! parents! of! patient! 41! is! unknown! and!we! do! not! have!295!
parental!DNA.!The!mother!of!patient!42!has!the!same!variant!and!a!clinical!phenotype!of!NS.!Patient!296!
43! had! isolated! short! stature! and! a! novel! heterozygous! c.3418T>A! (p.Leu1140Ile)! SOS1, variant!297!
predicted! disease! causing! by! Mutation! taster! (Table& 2).! This! patient’s! father! also! has! a! similar!298!
phenotype!of! isolated! short! stature! (b2.4! SDS)! but! parental!DNA!was!not! available! to! confirm! the!299!
segregation.!!300!
!301!




Analysis, 2:, 43! remaining! patients! (all! probands;! 38!with! GHI! and! 5! with! IGFb1! insensitivity)! were!306!
screened! for!variants! in!153!biological! candidate!growth!genes!associated!with:! syndromic!growth!307!
disorders,! skeletal! dysplasias,! growth! plate! biology,! cell! proliferation,! DNA! repair! or! growth!308!
retardation!in!mice!(Suppl.!Table&1).!!A!homozygous!variant!was!identified!in!one!patient!in!FANCA,309!
(c.2000C>G,!p.P667R;!mother!heterozygous,!paternal!DNA!not!available)!predicted!damaging!by!SIFT!310!
and!probably!damaging!by!PolyPhen.,A!homozygous!variant!was! identified! in!one!patient! in!PHKB,311!
(c.56b1G>A;!adopted!child!therefore!parental!DNA!not!available),!which!is!associated!with,glycogen!312!
storage! disease! type! IX! (GSD! IX).! This! alters! one! of! the! canonical! splice! site! bases! and! is! likely! to!313!
cause! exon! skipping! and! an! aberrant! protein.! 2! variants! were! identified! in! MDC1,314!
(c.3774_3775delGCinsAT,! p.P1259S! and! c.3528_3529delGCinsAT,! p.P1177S;! both! predicted!315!
tolerated/benign! by! PolyPhen! and! SIFT)! in! one! patient! and! 2! variants! in! another! patient! in, EVC2,316!
(c.673G>T,! p.A225S!;! and! c.664T>A,! p.F222I;! possibly! and! probably! deleterious! by! PolyPhen,!317!
respectively)! which! were! inherited! together! in! cis! from! one! parent! who! has! normal! stature.! The!318!





Analysis, 3:! In! light! of! the! dearth! of! variants! identified! by! analysis! 2,! WES! data! from! all! 43!323!
undiagnosed! patients! were! investigated! using! an! unbiased! approach.! This! strategy! produced! a!324!
shortlist!of!109!variants!in!77!candidate!genes.!Variants!in!all!77!genes!were!seen!in!GHI!patients!but!325!
only!4!genes!had!variants! in!patients!with!IGFb1! insensitivity!(*in!Supplementary&Table&3),!none!of!326!
which! were! specific! to! IGFb1! insensitivity.! PubMed! and! OMIM! did! not! reveal! obvious! growth!327!
associations!of!the!77!candidate!genes!and!pathway!analysis!did!not!reveal!any!enriched!functional!328!
pathways.! On! rare! variant! burden! testing,! none! of! the! 77! candidate! genes! were! found! to! be!329!




Although! there! was! significant! overlap,! patients! with! identified! genetic! defects! were! significantly!334!
shorter! compared! to! those! with! no! genetic! diagnosis! (mean! height! SDS! b5.2! vs! b3.7;! p<0.0001)!335!
(Figure&3).!Height!SDS!was!significantly!lower!in!patients!with!GHR!or!3M!gene!mutations!compared!336!




taking! this! limitation! into! account,! peak! GH! levels! were! significantly! higher! in! patients! with!GHR!341!
mutations,compared!to!those!with!no!genetic!diagnosis!(p=0.0177)&(Table&3).!Patients!with!GHR,6Ψ,342!
mutations! had! less! severe! phenotypes! when! compared! to! patients! with! other! homozygous, GHR,343!
defects! (Mean! height! SDS! b4.07! vs! b6.2! respectively,! p=0.0006)! as! previously! described26.!344!








short! stature.!Growth!hormone! (GHI)!and! IGFb1! insensitivity!encompass!a! spectrum!of!clinical!and!352!








Multiple! mutations! have! been! discovered! in! the! GHbIGFb1! axis! in! association! with! GH! and! IGFb1!361!
insensitivity!including!mutations!in!the!GH1,,GHR,,STAT5B,,IGFALS,,PAPPA2,,IGF1,and,IGF1R!genes1,!7.!362!
We!recently!noted!that,!as!well!as!the!classically!recognised!GHbIGFb1!axis!gene!defects,!other!short!363!
stature! disorders! may! have! features! of! GHI! such! as! 3M,! Noonan! and! SilverbRussell! (SRS)!364!
syndromes10.! Consequently,! we! now! routinely! screen! GHI! patients! born! small! for! gestational! age!365!












gene(s)! for! analysis! depending! on! the! patient’s! clinical! phenotype! and! hormonal! profile.! ! This!377!
approach! is! reliant! on! accurate! clinical! information! available! at! the! time!of! referral! and! is! usually!378!
restricted! to! a! small! number! of! genes! due! to! the! time! and! cost! implications.! In! contrast,! next!379!
generation! sequencing! techniques! such! as! targeted! gene! panels! can! be! employed! to! analyse! all!380!
genes!known!to!cause!a!genetically!heterogeneous!disorder!in!one!test.!Alternatively,!whole!exome!381!
sequencing! (WES),! allows! the! simultaneous! analysis! of! all! genes.! Although! gene! panels! can! be!382!





The! traditional! (CGS)!approach!alone!confirmed!a!diagnosis! in!35%!of!our! cohort! (31%!probands);!388!
the!majority!of!cases!(92%)!were!diagnosed!following!sequencing!of!1!or!2!genes.!This!technique!is!389!
therefore!relatively!reliable!if!the!phenotype!is!accurately!documented!and!is!typical!for!the!disorder!390!
e.g.!extreme!short! stature!and! IGFb1!deficiency! (IGFD)!with!classical! Laron!syndrome! features10,! 30.!391!
Interestingly,!we!isolated!a!further!8!genetic!variants!in!11!patients!in!GHI!genes!by!WES.!These!were!392!
not! initially! detected! by! CGS! either! because! the! variant! was! outside! of! the! region! amplified! by!393!
Sanger!sequencing!in!the!case!of!the!novel!homozygous!GHR!gene!mutation!identified!in!4!Kuwaiti!394!
patients!or!the!phenotype!was!atypical! (IGFALS,!PTPN11,,SOS1,,CCDC8,,CUL7).! ! In!the!final!Kuwaiti!395!
patient,! the! homozygous, GHR! mutation! had! been! missed! as! a! result! of! human! error.! Clinical!396!
phenotyping! can!be! challenging! for! even! experienced! clinicians! and!many! conditions! have! a!wide!397!
phenotypic! spectrum.! In! retrospect,! the! referring! clinicians! identified! clinical! features! associated!398!
with!Noonan!and!3M!syndromes!in!the!2!patients!with!previously!reported!PTPN11!mutations!and!399!
the!patients!with!CUL7! and!OBSL1!mutations,! respectively.! The!patient!with!a!novel!heterozygous!400!
! 16!
SOS1! gene! variant!was!born! SGA,!had! short! stature!and! IGFD!but!no! classical! features!of!NS.! The!401!
other! patient!with! novel! compound! heterozygous! IGFALS! gene! variants! is! shorter! (b5.0! SDS)! than!402!
most/all!previously!reported!patients!with!IGFALS!defects1.!This!emphasizes!not!only!the!importance!403!
of! accurate! clinical! phenotyping! prior! to! referral! for! genetic! testing! but! also! the! difficulties! in!404!





the! clinical! phenotype.!However,! familial! segregation! and! in, silico! prediction! programs!have! been!410!
utilized! to! substantiate! them.! Except! for! cases! 42! (compound! heterozygous! IGFALS)! and! 45!411!
(heterozygous!SOS1)!the!phenotypes!are!also!typical!for!the!identified!genetic!defects!1.!Therefore,!412!
we!are!confident!that!these!genetic!variants!explain!the!clinical!presentation.!According!to!ExAC,!the!413!
SOS1! gene! is! intolerant! of! loss! of! function! variants! (expected! number! of! loss! of! function! variants!414!
57.5;!observed!loss!of!function!variants!3,!pLI!=!1.0)!this!increases!the!likelihood!of!this!variant!being!415!
pathogenic.! The! IGFALS! variants! are! both! predicted! to! be! highly! deleterious! and! the! patient! had!416!
reduced! birth! weight! (SDS! b3.4).! Together! these! factors!may! contribute! to! the! development! of! a!417!
more!extreme!phenotype.!No!dysmorphic!features!or!other!potential!genetic!variants! in!candidate!418!










recognised! presenting! feature! in! children33.! Chromosome! breakage! test!with!mitomycin! C! (MMC)!428!
did!not!show!any!spontaneous!chromosome!fragility.!Unfortunately,!a!lack!of!chromosomal!fragility!429!
does!not!exclude!FA!and! further! investigations!are! currently!underway.!GSD! IX! is! caused!by!PHKB!430!
mutations!resulting!in!phosphorylase!kinase!deficiency.!The!novel,!predicted!damaging!homozygous!431!
mutation!was!identified!in!a!child!with!severe!short!stature!(b4.5!SDS)!and!IGFD!(b4.1!SDS).!PHKB!has!432!
an!autosomal! recessive!mode!of! inheritance!and! the! symptoms,! severity! and!prognosis! are!highly!433!
variable,! even! among! individuals! with! the! same! mutation.! Characteristic! features! include,!434!




The! identification!of!FA!and!GSD! in!children! is!crucial! to! initiate!close!monitoring! for!serious! longb439!
term!complications!(haematological!malignancies!/!hepatic!and!cardiac,!respectively)!and!studies!are!440!
underway! to! validate! these! diagnoses.! Ideally,! functional! studies! should! be! undertaken! to!441!
definitively! attribute! the! FANCA, and! PHKB, mutations! to! the! phenotypes.! Due! to! the! in, silico!442!
predictions!and!mode!of!inheritance!respectively,!the!MDC1,and,EVC2,variants!were!presumed!nonb443!
pathogenic!and!have!not!been!further!investigated.!The!molecular!diagnosis!of!all!but!2!patients!in!444!
the! cohort! could! have! potentially! been! secured! using! a! next! generation! sequencing! panel!445!




than! undertaking! CGS! of! the! 22! genes! known! to! cause!GH! and! IGFb1! insensitivity! (Analysis! 1)! i.e.!450!
approximately!£600!vs!£1750.!451!
!452!
The! identification! novel! genetic! causes! of! short! stature! is! essential! to! advance!our! understanding!453!
and!management!of!growth!disorders.!!To!address!this!we!used!an!unbiased!approach!(Analysis!3)!to!454!
! 18!
uncover! variants! in! genes,! which! might! represent! novel! aetiologies! for! short! stature.! No! strong!455!
candidate!gene(s)! emerged! from! this! analysis!but!we!hereby! report! the! results! for! reference.! The!456!




that! a! combination! of! both! these! factors!may! be! important.! As! we! were! unable! to! perform! trio!461!
analysis!on!all!patients,!we!may!have!missed!some!de,novo! variants!acting! in!a!dominant! fashion.!462!
Additionally,!CNV!or!unexplored!e.g.!intronic!or!regulatory!regions!of!the!known!genes!not!covered!463!
by!WES,! such!as! the,GHR! pseudoexon!mutation,!may! contribute! 26,! 28.! In! the! coming!years,!whole!464!
genome!sequencing!will!uncover!more!such!examples.!!465!
&466!
Deciding! which! short! patients! to! refer! for! genetic! testing! can! be! problematic.! Knowledge! of! the!467!
clinical!features!associated!with!different!gene!mutations!is!key!to!deciding!which!gene!to!prioritize.!468!
Our! data! suggests! that! accurate! assessment! of! height,! IGFb1! and!GH!may! improve! the! diagnostic!469!
yield.!Additionally,!a!genetic!defect! is!more!likely!to!be!identified!in!consanguineous!offspring.!The!470!










































































































































































37.! David!A,!MirakibMoud!F,! Shaw!NJ,! Savage!MO,!Clark!AJ!&!Metherell! LA.! Identification!and!635!









40.! Feigerlova! E,! Swinyard!M,! Derr!MA,! Farnsworth! J,! Andrew! SF,! Rosenfeld! RG! &! Hwa! V.! A!644!
novel! GHR! intronic! variant,! c.266+83G>T! ,! activates! a! cryptic! 5'! splice! site! causing! severe!645!
GHR! deficiency! and! classical! GH! insensitivity! syndrome.! Hormone, research, in, paediatrics,646!
2013!80!397b405.!647!
41.! Baumbach!L,!Schiavi!A,!Bartlett!R,!Perera!E,!Day!J,!Brown!MR,!Stein!S,!Eidson!M,!Parks!JS!&!648!
Cleveland! W.! Clinical,! biochemical,! and! molecular! investigations! of! a! genetic! isolate! of!649!
growth!hormone!insensitivity!(Laron's!syndrome).!J,Clin,Endocrinol,Metab,1997!82!444b451.!650!
42.! Amselem! S,! Sobrier! ML,! Duquesnoy! P,! Rappaport! R,! PostelbVinay! MC,! Gourmelen! M,!651!
Dallapiccola! B! &! Goossens! M.! Recurrent! nonsense! mutations! in! the! growth! hormone!652!






Hest! L,! Lund!AM,!Michaud! J,!Oley!C,!Patel!C,!Rajab!A,! Skidmore!DL,! Stewart!H,!Tauber!M,!659!
Munnich! A! &! CormierbDaire! V.! OBSL1! mutations! in! 3bM! syndrome! are! associated! with! a!660!
modulation!of!IGFBP2!and!IGFBP5!expression!levels.!Human,mutation,2010!31!20b26.!661!
45.! AlbDosari!MS,!AlbShammari!M,!Shaheen!R,!Faqeih!E,!Alghofely!MA,!Boukai!A!&!Alkuraya!FS.!662!



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































o genetic diagnosis 
G




















































































































































































































































































































































































































































































































































































153! biological! candidate! genes! which! are! associated! with! syndromic! growth! disorders,! skeletal! dysplasias,!
growth!plate!biology,!cell!proliferation,!DNA!replication!and!repair,!code!for!proteins!that!interact!with!partner!






























































ANKRD30A( 1! 2! MICA( 2! 4!
ANTXR2( 1! 2! MTCH2( 2! 3!
AQP7*( 1! 2! MUC17( 1! 2!
ARSD( 2! 4! MUC2( 2! 6!
BHLHE22( 2! 3! MUC5AC( 1! 3!
C11orf40( 1! 3! MUC6*( 2! 4!
C11orf80( 1! 2! MYO15B( 1! 3!
CAMKK2( 1! 2! NKAP( 1! 2!
CCDC66( 2! 4! NLRC5( 1! 3!
CD200R1( 1! 2! NOTCH4( 1! 3!
CD6( 1! 3! NPIPB8( 1! 3!
CDC42EP1( 1! 2! OR2T2/OR2T35( 1! 2!
CTBS( 1! 2! OR4A16( 4! 2!
DFNB59( 1! 2! OR51B6( 1! 2!
DSPP( 2! 4! OTOP1( 1! 2!
EI24( 1! 2! PABPC1( 2! 4!
FAM104B( 1! 2! PABPC3( 1! 2!
FAM174B( 1! 2! PODXL( 1! 3!
FAM188B( 1! 2! PRKRA( 1! 2!
FBXL21( 1! 3! PRSS3( 1! 2!
FNDC1( 1! 2! PSG8( 1! 2!
FRG2/FRG2B( 1! 3! RPL14( 1! 3!
GOLGA6L2( 4! 5! RXFP2( 1! 3!
GRIA3( 1! 2! SLC25A5( 2! 2!
GXYLT1( 3! 4! SLX4( 1! 3!
HGC6.3( 1! 2! SRRM3( 1! 3!
HLAHDRB1*( 4! 7! TAS2R19( 1! 3!
IGSF3( 1! 2! TAS2R31*( 1! 3!
JPH3( 1! 3! TAS2R43( 3! 3!
KIAA0040( 1! 2! TEKT4( 1! 2!
KRTAP4H5( 1! 2! UBXN11( 1! 2!
LCE4A( 1! 2! USF3( 1! 2!
LGALS8( 1! 3! ZAN( 1! 2!
LILRA3( 1! 2! ZFPM1( 1! 2!
LILRB1( 1! 2! ZNF534( 2! 3!
LOC100129697( 2! 5! ZNF598( 1! 2!
LOR( 1! 2! ZNF717( 6! 5!
MAFA( 1! 3! ZNF91( 2! 2!





Genes!were!selected! if! they!contained!variants!which!satisfied! the! following!criteria:! call!quality!at! least!20,!
read!depth!at! least!10,!allele!frequency!0.1%!or! less! in!any!of!the!1000!genomes,!ExAC,!and!all!of!the!NHLBI!
exomes.! Data! selected! was! outside! 0.1%! of! most! exonically! variable! 100! base! windows! in! healthy! public!
genomes!and!outside!0.1%!most!exonically!variable!genes! in!healthy!public!genomes!(1000!genomes,!ExAC).!
Predicted!deleterious!changes!were!defined!as!disease!associated!if!according!to!computed!ACMG!guidelines!
were! classified! as! pathogenic! or! likely! pathogenic! or! associated! with! loss! of! function! of! a! gene! being!
frameshift,! inUframe!indel,!or!start/stop!codon!change,!missense!or!spliceUsite!change!up!to!2!bases! into!the!




Supplementary, Table, 4.!Univariate, logistic, regression, analysis, of, age,, sex, and, consanguinity, as,
predictor,for,a,positive,genetic,diagnosis,,
,
Variable, p,value, Odds,Ratio, 95%,CI!Lower,Limit,
95%,CI!
Upper,Limit,
Age, 0.057, 0.92, 0.84, 1.003,
Sex, 0.25, 1.59, 0.72, 3.48,
Consanguinity, 0.0001, 18.29, 6.56, 51.06,
!
CI,!confidence!intervals.,
,
,
